Skip to main content
. 2018 Jun 22;9(48):28877–28896. doi: 10.18632/oncotarget.25608

Figure 6. Osteolytic cytokine and Wnt/BMP antagonist expression in αSMA positive cells and mesenchymal stem cells (MSCs) isolated from control bones and MDA-MB231 xenografts.

Figure 6

Relative expression levels of osteolytic cytokines (Rankl, Csf1) and Wnt/BMP antagonists (Dkk1, Dkk2, Dkk3, Sost, Chordin, Noggin, Frzb) in αSMA positive cells (A and B) and mesenchymal stem cells (MSCs) (C and D) isolated from control bones (A and C) and MDA-MB231 xenografts (B and D).